Literature DB >> 22287745

The expression of MAGE and SSX, and correlation of COX2, VEGF, and survivin in colorectal cancer.

Jongsoon Choi1, Heekyung Chang.   

Abstract

AIM/
PURPOSE: We investigated the expression of melanoma-associated antigen gene (MAGE), human synovial sarcoma on X chromosome (SSX) and their clinical implications in sporadic colon cancer.
MATERIALS AND METHODS: Fresh tissue samples from 37 patients with colorectal adenocarcinomas were analyzed for MAGE and SSX mRNA by reverse transcription-polymerase chain reaction (RT-PCR) and their paraffin-embedded tissues were used for immunohistochemistry for cyclooxygenase 2 (COX2), vascular endothelial growth factor (VEGF), and survivin.
RESULTS: Expression of MAGE and SSX was not detected in normal tissues. Colon cancer expressed SSX in 32.4% and MAGE in 51.4% of cases. Co-expression of MAGE and SSX was directly correlated with liver metastasis (p=0.024) and also correlated with nuclear expression of survivin (p=0.016), yet did not correlate with expression of COX2 and VEGF. Nuclear survivin expression (83.3%) was found in the cancer tissues exclusively. No significant relationships between the expression of COX2 (73.9%) and VEGF (72.4%) and other clinicopathologic variables were found.
CONCLUSION: Our results suggest that nuclear expression of survivin, lymph node metastasis, vascular and perineural invasion, and co-expression of MAGE and SSX may be associated with the metastasis of colorectal cancer to the liver.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22287745

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  13 in total

1.  Immunohistochemical expression and serum level of survivin protein in colorectal cancer patients.

Authors:  Katarzyna Jakubowska; Anna Pryczynicz; Violetta Dymicka-Piekarska; Waldemar Famulski; Katarzyna Guzińska-Ustymowicz
Journal:  Oncol Lett       Date:  2016-09-01       Impact factor: 2.967

2.  Immunohistochemical expression of nuclear and cytoplasmic survivin in gastrointestinal carcinoma.

Authors:  Michiko Shintani; Akiko Sangawa; Naoki Yamao; Shingo Kamoshida
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15

Review 3.  Somatic gene copy number alterations in colorectal cancer: new quest for cancer drivers and biomarkers.

Authors:  H Wang; L Liang; J-Y Fang; J Xu
Journal:  Oncogene       Date:  2015-08-10       Impact factor: 9.867

4.  Expression of MAGE-A and NY-ESO-1 in Primary and Metastatic Cancers.

Authors:  Tristen S Park; Eric M Groh; Krishna Patel; Sid P Kerkar; Chyi-Chia Richard Lee; Steven A Rosenberg
Journal:  J Immunother       Date:  2016-01       Impact factor: 4.456

Review 5.  CD20-negative diffuse large B cell lymphoma: a comprehensive analysis of 695 cases.

Authors:  Jing Li; Shu Zhao; Jingxuan Wang; Jingyu Chen; Wen Wen; Qingyuan Zhang
Journal:  Tumour Biol       Date:  2015-10-12

6.  A Panel of Cancer Testis Antigens and Clinical Risk Factors to Predict Metastasis in Colorectal Cancer.

Authors:  Ramyar Molania; Frouzandeh Mahjoubi; Rezvan Mirzaei; Saeed-Reza Khatami; Bahar Mahjoubi
Journal:  J Biomark       Date:  2014-03-09

7.  Clinicopathologic features of plasmablastic lymphoma: Single-center series of 8 cases from Saudi Arabia.

Authors:  Ghaleb Elyamany; Ali Matar Alzahrani; Muna Aljuboury; Najlah Mogadem; Nagham Rehan; Omar Alsuhaibani; Abdulaziz Alabdulaaly; Eman Al-Mussaed; Imad Elhag; Abdullah AlFiaar
Journal:  Diagn Pathol       Date:  2015-06-25       Impact factor: 2.644

8.  Gender-associated genomic differences in colorectal cancer: clinical insight from feminization of male cancer cells.

Authors:  Rola H Ali; Makia J Marafie; Milad S Bitar; Fahad Al-Dousari; Samar Ismael; Hussain Bin Haider; Waleed Al-Ali; Sindhu P Jacob; Fahd Al-Mulla
Journal:  Int J Mol Sci       Date:  2014-09-29       Impact factor: 5.923

9.  Analysis of the expression levels of survivin and VEGF in patients with acute lymphoblastic leukemia.

Authors:  Man Yang; Yongqiang Liu; Shufang Lu; Zhifen Wang; Ran Wang; Youmei Zi; Jingdong Li
Journal:  Exp Ther Med       Date:  2012-10-26       Impact factor: 2.447

10.  SSX2 is a novel DNA-binding protein that antagonizes polycomb group body formation and gene repression.

Authors:  Morten Frier Gjerstorff; Mette Marie Relster; Katrine Buch Viden Greve; Jesper Bonnet Moeller; Daniel Elias; Jonas Nørrelund Lindgreen; Steffen Schmidt; Jan Mollenhauer; Bjørn Voldborg; Christina Bøg Pedersen; Nadine Heidi Brückmann; Niels Erik Møllegaard; Henrik Jørn Ditzel
Journal:  Nucleic Acids Res       Date:  2014-09-23       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.